Furthermore, related studies have also found that USP38 effectively promotes vemurafenib-mediated inhibition of downstream molecules such as MMP and LAMP, thereby reducing the migration and invasion capabilities of tumor cells. This evidence concerns the gene USP38 and neoplasm.